Several studies have found that DHRS7 activity is reduced in prostate cancer patients (Araya et al., 2017); nonetheless, the expression of DHRS7 has been linked to cell proliferation and adhesion, suggesting that this molecule may operate as a tumor suppressor (Seibert et al., 2015). The gene discussed is DHRS7; the disease is prostate cancer.